Home Cart 0 Sign in  

[ CAS No. 6635-88-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 6635-88-7
Chemical Structure| 6635-88-7
Structure of 6635-88-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6635-88-7 ]

Related Doc. of [ 6635-88-7 ]

Alternatived Products of [ 6635-88-7 ]

Product Details of [ 6635-88-7 ]

CAS No. :6635-88-7 MDL No. :MFCD06657774
Formula : C7H6N2O Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 134.14 Pubchem ID :-
Synonyms :

Safety of [ 6635-88-7 ]

Signal Word: Class:
Precautionary Statements: UN#:
Hazard Statements: Packing Group:

Application In Synthesis of [ 6635-88-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6635-88-7 ]
  • Downstream synthetic route of [ 6635-88-7 ]

[ 6635-88-7 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 6635-88-7 ]
  • [ 101860-97-3 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 2
  • [ 6635-88-7 ]
  • [ 42732-49-0 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 3
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 4
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2697 - 2706
  • 5
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
  • [ 142892-30-6 ]
Reference: [1] Synthesis, 1992, # 6, p. 528 - 530
  • 6
  • [ 6635-88-7 ]
  • [ 10025-87-3 ]
  • [ 99310-62-0 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 7
  • [ 6635-88-7 ]
  • [ 101012-32-2 ]
YieldReaction ConditionsOperation in experiment
42.9% at 80℃; for 4.5 h; Heating / reflux (1-oxypyridin-3-yl)acetonitrile (7.5 g, 35.9 mmol) is carefully added to vigorously stirred phosphorous oxychloride (100 mL). The mixture is slowly heated to 80° C. (in 5° C. increments) over 1.5 hr. (CAUTION. If heating is too quick, violent decomposition occurs at ca 70° C.) All the solids dissolved. The reaction is heated at reflux for 3 hr. The excess phosphorous oxychloride is removed and the residue is cautiously treated with cold water. Saturated sodium bicarbonate is added to make the mixture basic, then it is extracted with ethyl acetate (3.x.). The combined extract is washed with brine, dried, filtered and concentrated. The residue is purified by chromatography eluting with pentane-10 to 100percent ether. The second compound off the column is the desired (2-chloropyridin-3-yl)acetonitrile (2.35 g, 42.9percent yield) a light brown solid.
20% for 3 h; Reflux (1-Oxypyridin-3-yl)acetonitrile (1115) (4.00 g, 29.8 mmol) was added slowly to a stirred solution of POCI3 (50 mL). The mixture was heated to 80 °C in 5 - 7 °C increments every 10 -15 minutes. The reaction was then heated at reflux for 3 hours. Excess POCI3 was removed by distillation and the brown residue carefully poured on to cold water (200 mL). A saturated solution NaHC03 (300 mL) was then added carefully. Solid NaHC03 was added in portions to the aqueous mixture until the evolution of gas ceased. The aqueous layer was separated in to two portions (250 mL each) and each portion was extracted with EtOAc (3x100 mL). The combined organic layers were washed with brine (200 mL) and dried over Na2S04. The solvent was removed and the residue purified by column chromatography on silica gel (0- 100percent EtOAc in petroleum benzine) to afford a mixture of two isomeric compounds. The mixture was re-purified by column chromatography on silica gel (0-40percent diethyl ether in petroleum benzine 40-80 °C) to afford the title compound (1116) (0.932 g, 20percent) as a white solid; 1 H NMR (400 MHz, CDCI3) 6 8.41 (dd, J = 4.8, 1.8 Hz, 1 H), 7.90 (ddt, J = 7,6, 1.7, 0.7 Hz, 1 H), 7.34 (dd, J = 7,6, 4.8 Hz, 1 H), 3.87 (s, 2H), LCMS Method C: rt 4,50 min; m/z 153 [M+H]+.
Reference: [1] Patent: US2005/54631, 2005, A1, . Location in patent: Page/Page column 23-24
[2] Patent: WO2014/27199, 2014, A1, . Location in patent: Page/Page column 141
[3] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
[4] Patent: WO2012/110773, 2012, A1, . Location in patent: Page/Page column 138; 139
  • 8
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2697 - 2706
  • 9
  • [ 6635-88-7 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
  • [ 142892-30-6 ]
Reference: [1] Synthesis, 1992, # 6, p. 528 - 530
  • 10
  • [ 6635-88-7 ]
  • [ 10025-87-3 ]
  • [ 99310-62-0 ]
  • [ 39891-09-3 ]
  • [ 101012-32-2 ]
Reference: [1] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
  • 11
  • [ 6635-88-7 ]
  • [ 61494-55-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2697 - 2706
[2] Journal of the American Chemical Society, 1959, vol. 81, p. 740,742
[3] Patent: WO2012/110773, 2012, A1,
[4] Patent: WO2014/27199, 2014, A1,
  • 12
  • [ 6635-88-7 ]
  • [ 7677-24-9 ]
  • [ 5912-34-5 ]
YieldReaction ConditionsOperation in experiment
66% With N,N-Dimethylcarbamoyl chloride In dichloromethane at 20℃; for 72 h; To a suspension of (1-oxy-pyridin-3-yl)-acetonitrile (10 g, 75 mmol) in anhydrous CH2Cl2 under a nitrogen atmosphere was added trimethylsilylcyanide (10.95 mL, 82 mmol) and dimethylcarbamoylchloride (7.55 mL, 82 mmol). The reaction mixture was stirred at room temperature for 72 hours and then concentrated. EtOAc (100 mL) was added to the residue and the organic phase was washed with 1 M NaOH (150 mL), dried over Na2SO4, filtered and concentrated. The resulting solid was purified by column chromatography (50percent EtOAc/hexanes) affording 7.08 g (66percent) of a yellow solid: mp 48-51 °C; MS (+) APCI m/z 144 [M+H]+. Ref: WO 9818796
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 9, p. 3331 - 3347
[2] Journal of Medicinal Chemistry, 2000, vol. 43, # 4, p. 675 - 682
[3] Patent: EP1147083, 2004, B1, . Location in patent: Page 49
[4] Organic Process Research and Development, 2010, vol. 14, # 4, p. 883 - 889
[5] Journal of Medicinal Chemistry, 2012, vol. 55, # 17, p. 7472 - 7479
  • 13
  • [ 6635-88-7 ]
  • [ 7677-24-9 ]
  • [ 79-44-7 ]
  • [ 5912-34-5 ]
Reference: [1] Patent: US6136821, 2000, A,
  • 14
  • [ 6635-88-7 ]
  • [ 5912-35-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2000, vol. 43, # 4, p. 675 - 682
[2] Organic Process Research and Development, 2010, vol. 14, # 4, p. 883 - 889
[3] Journal of Medicinal Chemistry, 2011, vol. 54, # 9, p. 3331 - 3347
[4] Journal of Medicinal Chemistry, 2012, vol. 55, # 17, p. 7472 - 7479
Same Skeleton Products
Historical Records